(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
0.00% $ 0.0510
Live Chart Being Loaded With Signals
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program...
Stats | |
---|---|
Dzisiejszy wolumen | 105 000 |
Średni wolumen | 239 691 |
Kapitalizacja rynkowa | 18.70M |
EPS | $0 ( 2024-02-25 ) |
Następna data zysków | ( $0 ) 2024-07-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.270 |
ATR14 | $0 (0.00%) |
Emerald Clinics Ltd Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Emerald Clinics Ltd Finanse
Annual | 2023 |
Przychody: | $1.59M |
Zysk brutto: | $-3.32M (-208.56 %) |
EPS: | $-0.0177 |
FY | 2023 |
Przychody: | $1.59M |
Zysk brutto: | $-3.32M (-208.56 %) |
EPS: | $-0.0177 |
FY | 2022 |
Przychody: | $1.82M |
Zysk brutto: | $-4.41M (-242.22 %) |
EPS: | $-0.0273 |
FY | 2021 |
Przychody: | $1.21M |
Zysk brutto: | $-1.06M (-87.51 %) |
EPS: | $-0.0284 |
Financial Reports:
No articles found.
Emerald Clinics Ltd
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej